Clinical trial
Treatment of Zollinger-Ellison Syndrome With Prevacid
NCT00204373 · Charles Mel Wilcox, MD, Other · Completed
Key facts
| NCT number | NCT00204373 |
|---|---|
| Title | Treatment of Zollinger-Ellison Syndrome With Prevacid |
| Official title | Long-Term Study of the Efficacy and Safety of Lansoprazole in the Treatment of Zollinger-Ellison and Other Acid Hypersecretors |
| Lead sponsor | Charles Mel Wilcox, MD, Other |
| Collaborators | Takeda Pharmaceuticals North America, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasia |
| Intervention type | Drug |
| Interventions | Lansoprazole (Prevacid) |
| Enrollment | 72 |
| Start date | Mar 1, 2003 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 30, 2012 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: